ABIO logo

ARCA Biopharma (ABIO) Shareholders Equity

Annual Shareholders Equity

$37.02 M
-$4.65 M-11.17%

December 31, 2023

Summary

Performance

1-Year Change

-11.17%

3-Year Change

-20.42%

5-Year Change

+513.73%

15-Year Change

+260.29%

ABIO Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$69.84 M
ABIO annual stockholders equity is currently -47.00% below its historical high of $69.84 million

3-Year Low

$37.02 M
ABIO annual stockholders equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ABIO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
ABIO next annual earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Annual Retained Earnings

-$188.74 M
ABIO annual retained earnings is -$188.74 million

Annual Working Capital

$36.79 M
ABIO annual working capital is $36.79 million

Annual Total Assets

$37.86 M
ABIO annual total assets is $37.86 million

Annual Total Liabilities

$841.00 K
ABIO annual total liabilities is $841.00 thousand

Quarterly Shareholders Equity

$32.57 M
-$2.55 M-7.27%

June 30, 2024

Summary

Performance

3-Month Change

-7.27%

1-Year Change

-12.01%

3-Year Change

-42.45%

5-Year Change

-42.45%

ABIO Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$153.85 M
ABIO quarterly stockholders equity is currently -78.83% below its historical high of $153.85 million

3-Year Low

$32.57 M
ABIO quarterly stockholders equity is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
ABIO previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
ABIO next earnings announcement has not yet been scheduled

OtherABIObalance sheetmetrics:

Quarterly Retained Earnings

-$193.43 M
ABIO quarterly retained earnings is -$193.43 million

Quarterly Working Capital

$32.55 M
ABIO quarterly working capital is $32.55 million

Quarterly Total Assets

$33.84 M
ABIO quarterly total assets is $33.84 million

Quarterly Total Liabilities

$1.27 M
ABIO quarterly total liabilities is $1.27 million

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

Annual Shareholders Equity

$37.02 M
ABIO annual stockholders equity is $37.02 million

Annual Total Assets

$37.86 M
ABIO annual total assets is $37.86 million

Annual Total Liabilities

$841.00 K
ABIO annual total liabilities is $841.00 thousand

ABIO Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-11.2%-12.0%
3 y3 years-20.4%-42.5%
5 y5 years+513.7%-42.5%

ABIO Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-27.5%at low-36.2%at low
5 y5-year-27.5%-79.4%-50.6%-80.6%
alltimeall time-47.0%-203.1%-78.8%-217.2%

ARCA Biopharma Shareholders Equity History

DateAnnualQuarterly
Jun 2024
-
$32.57 M(-7.3%)
Mar 2024
-
$35.13 M(-5.1%)
Dec 2023
$37.02 M(-11.2%)
$37.02 M(-2.5%)
Sep 2023
-
$37.97 M(-3.2%)
Jun 2023
-
$39.24 M(-3.2%)
Mar 2023
-
$40.53 M(-2.7%)
Dec 2022
$41.67 M(-18.4%)
$41.67 M(-2.5%)
Sep 2022
-
$42.73 M(-5.0%)
Jun 2022
-
$44.96 M(-6.2%)
Mar 2022
-
$47.94 M(-6.1%)
Dec 2021
$51.04 M(+9.7%)
$51.04 M(-9.8%)
Sep 2021
-
$56.60 M(-7.5%)
Jun 2021
-
$61.21 M(-7.1%)
Mar 2021
-
$65.91 M(+41.7%)
Dec 2020
$46.52 M(+511.3%)
$46.52 M(-7.8%)
Sep 2020
-
$50.45 M(+389.6%)
Jun 2020
-
$10.30 M(+63.4%)
Mar 2020
-
$6.31 M(-17.1%)
Dec 2019
$7.61 M(+26.2%)
$7.61 M(-13.5%)
Sep 2019
-
$8.80 M(-4.2%)
Jun 2019
-
$9.19 M(+25.6%)
Mar 2019
-
$7.32 M(+21.3%)
Dec 2018
$6.03 M(-41.3%)
$6.03 M(-19.2%)
Sep 2018
-
$7.46 M(-17.1%)
Jun 2018
-
$9.00 M(-18.6%)
Mar 2018
-
$11.05 M(+7.6%)
Dec 2017
$10.28 M(-53.7%)
$10.28 M(-28.4%)
Sep 2017
-
$14.35 M(-2.7%)
Jun 2017
-
$14.75 M(-18.2%)
Mar 2017
-
$18.04 M(-18.7%)
Dec 2016
$22.19 M(-41.7%)
$22.19 M(-16.2%)
Sep 2016
-
$26.48 M(-14.3%)
Jun 2016
-
$30.89 M(-10.7%)
Mar 2016
-
$34.58 M(-9.2%)
Dec 2015
$38.07 M(+158.3%)
$38.07 M(-7.4%)
Sep 2015
-
$41.09 M(-6.1%)
Jun 2015
-
$43.76 M(+260.8%)
Mar 2015
-
$12.13 M(-17.7%)
Dec 2014
$14.74 M(-5.4%)
$14.74 M(-14.3%)
Sep 2014
-
$17.20 M(-11.0%)
Jun 2014
-
$19.32 M(-10.3%)
Mar 2014
-
$21.53 M(+38.2%)
Dec 2013
$15.58 M(+436.0%)
$15.58 M(-15.2%)
Sep 2013
-
$18.37 M(-8.3%)
Jun 2013
-
$20.03 M(+505.0%)
Mar 2013
-
$3.31 M(+13.9%)
Dec 2012
$2.91 M(-49.3%)
$2.91 M(-8.5%)
Sep 2012
-
$3.18 M(-3.4%)
Jun 2012
-
$3.29 M(-24.5%)
Mar 2012
-
$4.36 M(-24.0%)
Dec 2011
$5.73 M(-15.3%)
$5.73 M(-1.4%)
Sep 2011
-
$5.81 M(-23.0%)
Jun 2011
-
$7.54 M(+62.5%)
Mar 2011
-
$4.64 M(-31.4%)
Dec 2010
$6.77 M
$6.77 M(-20.0%)
DateAnnualQuarterly
Sep 2010
-
$8.47 M(-19.1%)
Jun 2010
-
$10.46 M(-13.1%)
Mar 2010
-
$12.04 M(+62.4%)
Dec 2009
$7.41 M(-119.4%)
$7.41 M(-45.2%)
Sep 2009
-
$13.52 M(-21.7%)
Jun 2009
-
$17.26 M(-31.9%)
Mar 2009
-
$25.32 M(-166.3%)
Dec 2008
-$38.18 M(-156.4%)
-$38.18 M(-185.4%)
Sep 2008
-
$44.72 M(-14.6%)
Jun 2008
-
$52.35 M(+1.4%)
Mar 2008
-
$51.62 M(-23.7%)
Dec 2007
$67.66 M(-3.1%)
$67.66 M(-12.6%)
Sep 2007
-
$77.43 M(-12.8%)
Jun 2007
-
$88.82 M(+56.2%)
Mar 2007
-
$56.88 M(-18.6%)
Dec 2006
$69.84 M(+23.0%)
$69.84 M(-41.5%)
Sep 2006
-
$119.35 M(-15.0%)
Jun 2006
-
$140.40 M(-8.7%)
Mar 2006
-
$153.85 M(+171.0%)
Dec 2005
$56.76 M(+24.5%)
$56.76 M(-11.4%)
Sep 2005
-
$64.05 M(-22.9%)
Jun 2005
-
$83.04 M(-16.8%)
Mar 2005
-
$99.86 M(+119.0%)
Dec 2004
$45.59 M(+100.8%)
$45.59 M(-22.1%)
Sep 2004
-
$58.52 M(-13.4%)
Jun 2004
-
$67.57 M(-14.1%)
Mar 2004
-
$78.65 M(+246.5%)
Dec 2003
$22.70 M(-597.4%)
$22.70 M(+364.7%)
Sep 2003
-
$4.88 M(-68.0%)
Jun 2003
-
$15.26 M(-50.1%)
Mar 2003
-
$30.58 M(-770.0%)
Dec 2002
-$4.56 M(-129.6%)
-$4.56 M(-139.0%)
Sep 2002
-
$11.69 M(-10.5%)
Jun 2002
-
$13.06 M(+93.8%)
Mar 2002
-
$6.74 M(-56.3%)
Dec 2001
$15.42 M(+84.4%)
$15.42 M(-37.5%)
Sep 2001
-
$24.68 M(+79.6%)
Jun 2001
-
$13.74 M(-37.4%)
Mar 2001
-
$21.93 M(+162.3%)
Dec 2000
$8.36 M(-71.4%)
$8.36 M(-42.7%)
Sep 2000
-
$14.60 M(-19.4%)
Jun 2000
-
$18.12 M(-21.5%)
Mar 2000
-
$23.07 M(-21.0%)
Dec 1999
$29.20 M(-38.7%)
$29.20 M(-14.6%)
Sep 1999
-
$34.20 M(-10.9%)
Jun 1999
-
$38.40 M(-10.5%)
Mar 1999
-
$42.90 M(-9.9%)
Dec 1998
$47.60 M(-24.3%)
$47.60 M(-8.1%)
Sep 1998
-
$51.80 M(-9.4%)
Jun 1998
-
$57.20 M(-5.3%)
Mar 1998
-
$60.40 M(-4.0%)
Dec 1997
$62.90 M(+750.0%)
$62.90 M(-2.0%)
Sep 1997
-
$64.20 M(+349.0%)
Jun 1997
-
$14.30 M(+155.4%)
Mar 1997
-
$5.60 M
Dec 1996
$7.40 M
-

FAQ

  • What is ARCA biopharma annual stockholders equity?
  • What is the all time high annual shareholders equity for ARCA biopharma?
  • What is ARCA biopharma annual shareholders equity year-on-year change?
  • What is ARCA biopharma quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for ARCA biopharma?
  • What is ARCA biopharma quarterly shareholders equity year-on-year change?

What is ARCA biopharma annual stockholders equity?

The current annual shareholders equity of ABIO is $37.02 M

What is the all time high annual shareholders equity for ARCA biopharma?

ARCA biopharma all-time high annual stockholders equity is $69.84 M

What is ARCA biopharma annual shareholders equity year-on-year change?

Over the past year, ABIO annual stockholders equity has changed by -$4.65 M (-11.17%)

What is ARCA biopharma quarterly stockholders equity?

The current quarterly shareholders equity of ABIO is $32.57 M

What is the all time high quarterly shareholders equity for ARCA biopharma?

ARCA biopharma all-time high quarterly stockholders equity is $153.85 M

What is ARCA biopharma quarterly shareholders equity year-on-year change?

Over the past year, ABIO quarterly stockholders equity has changed by -$4.45 M (-12.01%)